Alcohol and Metabolic Syndrome Interaction.


Journal

Clinics in liver disease
ISSN: 1557-8224
Titre abrégé: Clin Liver Dis
Pays: United States
ID NLM: 9710002

Informations de publication

Date de publication:
Nov 2024
Historique:
medline: 4 10 2024
pubmed: 4 10 2024
entrez: 3 10 2024
Statut: ppublish

Résumé

Alcohol-related liver disease and metabolic-dysfunction-associated steatotic liver disease are the most common causes of chronic liver disease. Globally, alcohol intake, and metabolic syndrome driven by excessive caloric intake and sedentary lifestyle have steadily increased over the past decades. Given the high prevalence rates of both excessive alcohol consumption and components of metabolic syndrome, both can frequently coexist in the same individuals and impact their lives. In this article, we review the impact of alcohol and metabolic syndrome on liver-related outcomes.

Identifiants

pubmed: 39362710
pii: S1089-3261(24)00050-3
doi: 10.1016/j.cld.2024.06.002
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

601-620

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure Dr Z. M. Younossi is a consultant to BMS, GSK, Cymabay, Ipsen, Abbott, Novo Nordisk, Madrigal, Merck, Siemens, and Intercept. Other authors have no conflict of interest to disclose.

Auteurs

Ryuki Hashida (R)

Beatty Liver and Obesity Research Program, Inova Health System, 3300 Gallows Road, Falls Church, VA, USA; Division of Rehabilitation, Kurume University Hospital, Kurume 830-0011, Japan; Department of Orthopedics, Kurume University School of Medicine, Kurume 830-0011, Japan.

Pegah Golabi (P)

Beatty Liver and Obesity Research Program, Inova Health System, 3300 Gallows Road, Falls Church, VA, USA; The Global NASH Council, 2411 I Street, Washington DC, USA.

Janus Ong (J)

College of Medicine, University of the Philippines, Manila, Philippines; The Global NASH Council, 2411 I Street, Washington DC, USA.

Takumi Kawaguchi (T)

Division of Rehabilitation, Kurume University Hospital, Kurume 830-0011, Japan; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan.

Zobair M Younossi (ZM)

Beatty Liver and Obesity Research Program, Inova Health System, 3300 Gallows Road, Falls Church, VA, USA; The Global NASH Council, 2411 I Street, Washington DC, USA. Electronic address: zobair.younossi@cldq.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH